2-85327016-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006464.4(TGOLN2):c.716G>T(p.Gly239Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
TGOLN2
NM_006464.4 missense
NM_006464.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: -3.74
Genes affected
TGOLN2 (HGNC:15450): (trans-golgi network protein 2) This gene encodes a type I integral membrane protein that is localized to the trans-Golgi network, a major sorting station for secretory and membrane proteins. The encoded protein cycles between early endosomes and the trans-Golgi network, and may play a role in exocytic vesicle formation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.033337444).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGOLN2 | NM_006464.4 | c.716G>T | p.Gly239Val | missense_variant | 2/4 | ENST00000377386.8 | NP_006455.2 | |
TGOLN2 | NM_001368095.1 | c.716G>T | p.Gly239Val | missense_variant | 2/4 | NP_001355024.1 | ||
TGOLN2 | NM_001368096.1 | c.716G>T | p.Gly239Val | missense_variant | 2/4 | NP_001355025.1 | ||
TGOLN2 | NM_001206844.2 | c.716G>T | p.Gly239Val | missense_variant | 2/5 | NP_001193773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGOLN2 | ENST00000377386.8 | c.716G>T | p.Gly239Val | missense_variant | 2/4 | 1 | NM_006464.4 | ENSP00000366603 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 37
GnomAD4 exome
Cov.:
37
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.716G>T (p.G239V) alteration is located in exon 2 (coding exon 2) of the TGOLN2 gene. This alteration results from a G to T substitution at nucleotide position 716, causing the glycine (G) at amino acid position 239 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L;.;L
MutationTaster
Benign
N;N;N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T
Polyphen
P;B;D;.;.;P
Vest4
MutPred
Loss of glycosylation at S238 (P = 0.0358);Loss of glycosylation at S238 (P = 0.0358);Loss of glycosylation at S238 (P = 0.0358);Loss of glycosylation at S238 (P = 0.0358);Loss of glycosylation at S238 (P = 0.0358);Loss of glycosylation at S238 (P = 0.0358);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.